Additional information

Please visit the EFPIA website to receive further information about the EFPIA Disclosure Code.

EFPIA Disclosure (Transparency) Code

Working with Healthcare Professionals and Organisations - Disclosure (Transparency) Code

Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and supports the EFPIA Disclosure (Transparency) Code. As a member of EFPIA we are fully committed to publishing details of our collaboration with healthcare professionals (HCPs) and healthcare organisations (HCOs) to demonstrate that we interact with HCPs and HCOs in an ethical and transparent way.

Starting in 2015 certain defined transfers of value provided by pharmaceutical companies to HCPs and HCOs are collected and reported during the subsequent calendar year. The transfers of value covered by this requirement are:

  • Grants and donations to HCOs
  • Speaker and consultancy fees for HCPs
  • Sponsorship of events organised by or on behalf of HCOs
  • Support of HCPs to attend congresses and educational or scientific meetings
  • Research and development related transfers of value (only as an aggregated report

The first data was published at the end of June 2016 together with a methodological note describing how Grünenthal has collected and disclosed the data in the reports. Transfers of value to HCPs and HCOs are published in the country of the recipient’s principle practice, and include transfers of value which are made by any other Grünenthal affiliate.

 

Disclosure in Ireland

The Irish Pharmaceutical Healthcare Association (IPHA) has stipulated in its Code of Practice for the Pharmaceutical Industry that member companies disclose their data in a central report hosted by IPHA: www.transferofvalue.ie.

Information regarding the disclosure of transfers of value in Ireland can be accessed directly from the IPHA website: please click here.

Support provided to patient organisations is not disclosed within the central report. To see details of the support provided by Grünenthal to patient organisations and other groups in our local community, please click here.

Date of Preparation: March 2017 IRE/G17 0005